Skip to main content

Table 2 Factors associated with higher mortality at day 30 in patients with CMV infection (n = 56)

From: Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy

Type of analysisUnivariate OR (95% CI)Multivariate OR (95% CI)
Age in years, older than 39.0.611 (1.52–245) p = 0.485 
ART*, yes4.1 (0.97–17.31) p = 0.044 
ICU admission, yes32.4 (3.65–287.06) p = 0.0001 
Mechanical Ventilation, yes84 (8.27–853.12) p = 0.000184 (8–853) p = 0.0001
HIV viral load, less than 284,000 copies/ml2.77 (0.638–12.1) p = 0.163 
CD4, less than 30 cells/mm30.56 (0.13–2.52), p = 0.411 
CMV*** BAL VL, less than 5300 copies/ml1.5 (0.85–2.64), p = 0.121 
CMV**** blood VL less than 3700 copies/ml3.8 (0.67–13.11) P 0.114 
Co morbidities, yes1.25 (0.3–5) p = 0.755 
  1. * antiretroviral therapy***Cytomegalovirus bronchoalveolar viral load, ****Cytomegalovirus blood viral load
  2. Bold formatting represents significant P values